Initial AlloNK® (AB-101) clinical data demonstrated 71% ACR50 response in refractory rheumatoid arthritis (RA) patients with ...
Penetration tests of AI systems expose significantly higher severe-flaw density when compared to legacy apps. New attack ...
A turning point came in 2019, when Kevin Hall, then a senior investigator with the National Institute of Diabetes and ...